Economic aspects of enhanced testing strategies for respiratory diseases

M. POSTMA (Groningen, Netherlands)

Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Number: 0
Disease area: Respiratory infections

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. POSTMA (Groningen, Netherlands). Economic aspects of enhanced testing strategies for respiratory diseases. Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


Current treatments for respiratory infections in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005


Efficiency of the specific and nonspecific means for prevention of pneumonia and respiratory infections in recruits
Source: Eur Respir J 2005; 26: Suppl. 49, 143s
Year: 2005

Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006

Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011



Spread of carriage of pneumonia and acute respiratory diseases (ARS) agents in recruits
Source: Eur Respir J 2005; 26: Suppl. 49, 144s
Year: 2005

Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011



Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85
Source: Eur Respir Rev 2005; 14: 74-77
Year: 2005



Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators
Source: Eur Respir J 2007; 30: 556-573
Year: 2007



Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018


Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005



Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019


Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006

Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004

Developing outcome-based guidelines in CAP and AECB
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005